HopeStage
Back to all studies
CompletedNCT04560868

A mobile app for smokers who feel unsure about quitting

About this titleRead the official source — NCT04560868
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
SeattleSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 16, 2020
Recruitment status
Completed
Enrollment listed in the registry
57
Sponsor
Kaiser Permanente
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Device, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04560868
Official title
Show the full official title

Development of a mHealth Intervention for Ambivalent Smokers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Kaiser Permanente.

Did this study involve medication?

Yes. The study involved medication, including Nicotine patch.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies